David Fajgenbaum

So as opposed to you taking one of the medicines and monitoring your symptoms, you were actually able to apply the medicine to your blood in some kind of way.

Hard was just the figuring out which of these T cells or immune cells were the ones that were problematic.

That feels hard enough right there.

Because I'm like asking for this IVIG.

That was going to be one of my questions.

Were you able to prescribe yourself this stuff because you had your medical degree or were you reliant?

And how hard is it to get other doctors to sign on to this approach?

It was like a 10-year-old drug at the time.

Been on the market 15 years.

The question I don't want to ask, but I got to ask is how many of these drugs your body kind of adapts?

Well, to me, Eleven's like, you've definitely passed that window where stuff stops.

Okay, so you come out of this and I don't know in order, but you get a job as a professor at Penn in the medical school.

That's right.

And you have a lab.

Yep.

And you decide to really dedicate yourself to exploring these other 18,000 diseases with these 4,000 medicines that exist to see what off-label stuff could exist.

Are you immediately employing AI?

When does AI enter the picture?

Because it's got to be almost impossible without AI.

You would.